China has approved early human testing for two experimental coronavirus vaccines as it struggles to stem imported cases and prevent a second wave of corona virus.
The experimental vaccines are being developed by a Beijing-based unit of Sinovac Biotech and the Wuhan Institute of Biological Products, a subsidiary of the state-owned China National Pharmaceutical Group, the state-run news agency Xinhua reported on Tuesday. China’s national health commission also confirmed that the trials will continue.
In March, Beijing gave the go-ahead to another clinical trial for a corona virus vaccine candidate developed by the military-backed Academy of Military Medical Sciences and biotech company CanSino Bio, shortly after US drug developer Moderna announced that to have started human tests for her vaccine, the US National Institutes of Health.
“We can now confirm that three specific vaccines are being tested in China, and the National Health Commission has announced that it will have to address a number of conditions before it can enable mass production of the vaccines worldwide.”
As of Tuesday, China reported 82,249 coronavirus cases and 3,341 deaths. There have been no deaths in the past 24 hours.